Department of Community Medicine, West Virginia University School of Medicine, PO Box 9190, Morgantown, WV 26506-9190, USA.
Clin Exp Nephrol. 2011 Feb;15(1):92-9. doi: 10.1007/s10157-010-0361-5. Epub 2010 Nov 3.
Microalbuminuria and plasma homocysteine levels are both considered to be markers of endothelial dysfunction and shown to be predictors of cardiovascular disease (CVD) in epidemiological studies. However, previous studies examining the association between plasma homocysteine and microalbuminuria have suggested that this association is explained by confounding factors such as preexisting CVD, diabetes, hypertension, and reduced kidney function.
We examined the association between plasma homocysteine and microalbuminuria in a representative sample of US men and women aged ≥ 20 years, who were free of diabetes mellitus, hypertension, and CVD and who participated in the Third National Health and Nutrition Examination Survey (n = 3,948). Microalbuminuria was defined as urinary albumin-to-creatinine ratio ≥ 30 mg/g.
Plasma homocysteine levels were positively associated with microalbuminuria in men but not in women (p-interaction <0.0001) after adjusting for age, race/ethnicity, smoking, drinking, body mass index, physical activity, glomerular filtration rate, blood pressure, high-density lipoprotein cholesterol, glycated hemoglobin, serum folate, serum vitamin B(12), and C-reactive protein. In men, the multivariable odds ratio (OR) [95% confidence interval (CI)] of microalbuminuria comparing the highest to the lowest quartile of homocysteine was 5.17 (2.00-13.36); (p-trend = 0.005). Further, men in the highest quartile of homocysteine and age ≥ 60 years had >12-fold odds of microalbuminuria compared with men in the lowest homocysteine quartile and age <60 years. In contrast, in women, the multivariable OR (95% CI) comparing the highest to the lowest quartile of homocysteine was 0.96 (0.86-1.07); (p-trend = 0.41).
Among relatively healthy adults, plasma homocysteine levels are associated with microalbuminuria only in men.
微量白蛋白尿和血浆同型半胱氨酸水平均被认为是血管内皮功能障碍的标志物,并在流行病学研究中被证实是心血管疾病(CVD)的预测因子。然而,先前研究检查血浆同型半胱氨酸与微量白蛋白尿之间的关系表明,这种关联可以通过先前存在的 CVD、糖尿病、高血压和肾功能减退等混杂因素来解释。
我们在一个代表性的美国 20 岁及以上、无糖尿病、高血压和 CVD 的男性和女性样本中检查了血浆同型半胱氨酸与微量白蛋白尿之间的关系,他们参加了第三次国家健康和营养检查调查(n = 3948)。微量白蛋白尿定义为尿白蛋白/肌酐比值≥30mg/g。
在调整年龄、种族/民族、吸烟、饮酒、体重指数、体力活动、肾小球滤过率、血压、高密度脂蛋白胆固醇、糖化血红蛋白、血清叶酸、血清维生素 B12 和 C 反应蛋白后,血浆同型半胱氨酸水平与男性的微量白蛋白尿呈正相关,但与女性无关(p 交互<0.0001)。在男性中,与同型半胱氨酸最低四分位数相比,同型半胱氨酸最高四分位数的微量白蛋白尿的多变量比值比(OR)[95%置信区间(CI)]为 5.17(2.00-13.36);(p 趋势=0.005)。此外,与同型半胱氨酸最低四分位数和年龄<60 岁的男性相比,同型半胱氨酸最高四分位数且年龄≥60 岁的男性发生微量白蛋白尿的几率高出 12 倍以上。相比之下,在女性中,与同型半胱氨酸最低四分位数相比,同型半胱氨酸最高四分位数的多变量 OR(95%CI)为 0.96(0.86-1.07);(p 趋势=0.41)。
在相对健康的成年人中,只有男性的血浆同型半胱氨酸水平与微量白蛋白尿相关。